Patents/Assignees

LIPOCYTE BIOMED GmbH

1 patent in portfolio

US12049669utility2024
Use of the IL-6 Gene Expression Level for Classification of a Subject in Risk Groups in the Prognosis or Diagnosis of Type II Diabetes Mellitus
0 cites